Characteristics | Crude OR, DAH30 < 15 ± 95% CI | Adjusted OR, DAH30 < 15 ± 95% CI |
---|---|---|
Non-diabetics | 1.00 (reference) | 1.00 (reference) |
DM, type 1 | 2.17 (2.01–2.33) | 1.42 (1.30–1.54) |
DM, type 2 | 2.14 (2.06–2.23) | 1.13 (1.09–1.19) |
DM, unspecified | 3.67 (1.85–6.85) | 1.44 (0.66–3.01) |
Age | 1.04 (1.04–1.04) | 1.01 (1.01–1.02) |
Women | 0.80 (0.78–0.82) | 0.96 (0.94–0.99) |
Men | 1.00 (reference) | 1.00 (reference) |
ASA class | ||
ASA 1 | 1.00 (reference) | 1.00 (reference) |
ASA 2 | 3.66 (3.47–3.86) | 2.67 (2.52–2.83) |
ASA 3 | 15.20 (14.40–16.00) | 7.32 (6.91–7.76) |
ASA 4 | 68.70 (64.00–73.70) | 25.60 (23.70–27.60) |
Year of surgery | ||
2007–2010 | 1.00 (reference) | 1.00 (reference) |
2011–2014 | 0.91 (0.89–0.93) | 0.75 (0.73–0.77) |
Type of surgery | ||
Acute | 3.25 (3.17–3.33) | 2.71 (2.63–2.79) |
Elective | 1.00 (reference) | 1.00 (reference) |
Cancer | 1.61 (1.57–1.65) | 2.75 (2.65–2.85) |
Neuro | 3.84 (3.72–3.97) | 2.90 (2.78–3.03) |
Endocrine | 0.09 (0.07–0.11) | 0.17 (0.13–0.20) |
Ophthalmic | 0.12 (0.09–0.15) | 0.14 (0.11–0.19) |
Ear, nose, and throat | 0.19 (0.16–0.22) | 0.36 (0.31–0.42) |
Oral and maxillofacial | 0.19 (0.17–0.22) | 0.35 (0.31–0.40) |
Thoracic non-cardiac | 3.00 (2.77–3.25) | 1.60 (1.46–1.76) |
Breast | 0.03 (0.02–0.04) | 0.03 (0.03–0.04) |
Abdominal | 1.23 (1.19–1.26) | 0.96 (0.92–1.00) |
Urologic | 0.37 (0.35–0.39) | 0.29 (0.27–0.31) |
Gynecologic | 0.18 (0.16–0.20) | 0.29 (0.26–0.32) |
Orthopedic | 1.00 (reference) | 1.00 (reference) |
Vascular | 1.24 (1.17–1.31) | 0.74 (0.69–0.78) |
Dermatologic | 1.31 (1.22–1.40) | 1.02 (0.94–1.10) |